Concepedia
Statistics
Publications
13
Citations
534
H-Index
Active since
2013
Affiliations
University of Minho(Current)
Hospital de Câncer de Barretos
Hospital Braga
Genomic Health (United States)
Hospital de São João
Ana Xavier‐Magalhães is an author at University of Minho specializing in oncology, molecular oncology, and glioblastoma.
Publications per year
2013–2024
Disruption of the β1L Isoform of GABP Reverses Glioblastoma Replicative Immortality in a TERT Promoter Mutation-Dependent Manner
Andrew Mancini, Ana Xavier‐Magalhães, Wendy S. Woods et al. · Cancer Cell · 2018 · 149 citations · Full text
Medicine, Molecular Biology, Oncology +14
A transcriptomic signature mediated by HOXA9 promotes human glioblastoma initiation, aggressiveness and resistance to temozolomide
Marta Pojo, Céline S. Gonçalves, Ana Xavier‐Magalhães et al. · Oncotarget · 2015 · 60 citations · Full text
Medicine, Molecular Biology, Oncology +17
Systematic discovery of neoepitope–HLA pairs for neoantigens shared among patients and tumor types
Hem R. Gurung, Amy Heidersbach, Martine Darwish et al. · Nature Biotechnology · 2023 · 46 citations · Full text
Life Sciences, Immunology, Oncology +17
Effects of the functional HOTAIR rs920778 and rs12826786 genetic variants in glioma susceptibility and patient prognosis
Ana Xavier‐Magalhães, Ana I. Oliveira, Joana Vieira de Castro et al. · Journal of Neuro-Oncology · 2017 · 45 citations
Life Sciences, Genetics, Molecular Genetics +14
The long non-coding RNA<i>HOTAIR</i>is transcriptionally activated by HOXA9 and is an independent prognostic marker in patients with malignant glioma
Ana Xavier‐Magalhães, Céline S. Gonçalves, Anne Fogli et al. · Oncotarget · 2018 · 42 citations · Full text
Medicine, Genetics, Oncology +17
1–5 of 13